Valerie S. Hawthorne, Ph.D. - Publications

Affiliations: 
2006 The University of Texas Graduate School of Biomedical Sciences at Houston 
Area:
Oncology, Cell Biology

5 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2010 Li S, Hawthorne VS, Neal CL, Sanghera S, Xu J, Yang J, Guo H, Steeg PS, Yu D. Abstract 262: Upregulation of neutrophil gelatinase-associated lipocalin by ErbB2 through NF-κB activation Cancer Research. 70: 262-262. DOI: 10.1158/1538-7445.Am10-262  0.632
2009 Li SH, Hawthorne VS, Neal CL, Sanghera S, Xu J, Yang J, Guo H, Steeg PS, Yu D. Upregulation of neutrophil gelatinase-associated lipocalin by ErbB2 through nuclear factor-kappaB activation. Cancer Research. 69: 9163-8. PMID 19951994 DOI: 10.1158/0008-5472.Can-09-2483  0.633
2009 Hawthorne VS, Huang WC, Neal CL, Tseng LM, Hung MC, Yu D. ErbB2-mediated Src and signal transducer and activator of transcription 3 activation leads to transcriptional up-regulation of p21Cip1 and chemoresistance in breast cancer cells. Molecular Cancer Research : McR. 7: 592-600. PMID 19372587 DOI: 10.1158/1541-7786.Mcr-08-0316  0.547
2005 Younes MN, Yigitbasi OG, Park YW, Kim SJ, Jasser SA, Hawthorne VS, Yazici YD, Mandal M, Bekele BN, Bucana CD, Fidler IJ, Myers JN. Antivascular therapy of human follicular thyroid cancer experimental bone metastasis by blockade of epidermal growth factor receptor and vascular growth factor receptor phosphorylation. Cancer Research. 65: 4716-27. PMID 15930290 DOI: 10.1158/0008-5472.Can-04-4196  0.355
2004 Hawthorne VS, Yu D. PI3K: Missense Mutation Motivates Malignancy. Cancer Biology & Therapy. 3: 776-7. PMID 15280668 DOI: 10.4161/Cbt.3.8.1031  0.498
Show low-probability matches.